Case Report: CBD Cigarettes for Harm Reduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder.

Meyer, Maximilian; Walter, Marc; Borgwardt, Stefan; Scheidegger, Alexandra; Lang, Elisabeth; Köck, Patrick

Meyer, Maximilian; Walter, Marc; Borgwardt, Stefan; Scheidegger, Alexandra; Lang, Elisabeth; Köck, Patrick.

Afiliación

Meyer M; Department of Psychiatry (Universitäre Psychiatrische Kliniken), University of Basel, Basel, Switzerland.
Walter M; Department of Psychiatry (Universitäre Psychiatrische Kliniken), University of Basel, Basel, Switzerland.
Borgwardt S; Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.
Scheidegger A; Department of Psychiatry (Universitäre Psychiatrische Kliniken), University of Basel, Basel, Switzerland.
Lang E; Department of Psychiatry (Universitäre Psychiatrische Kliniken), University of Basel, Basel, Switzerland.
Köck P; Department of Psychiatry (Universitäre Psychiatrische Kliniken), University of Basel, Basel, Switzerland.

Front Psychiatry ; 12: 712110, 2021.

Article en En | MEDLINE | ID: mdl-34366942

Palabras clave

cannabidiol; case report; psychosis; schizophrenia; substance use disorder

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Plantas_medicinales Idioma: En Revista: Front Psychiatry Año: 2021 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google